A patient with worsening contact dermatitis and confirmed secondary infection with Staphylococcus aureus is being treated with oral antibiotics and topical corticosteroids. The patient also has asthma, which has been slightly exacerbated. Which nursing intervention is most important to include in the patient's care plan to prevent further complications?

C) Monitor the patient's respiratory status and ensure adequate asthma control.

A) Encourage the patient to increase fluid intake to promote hydration and skin healing.

B) Educate the patient on the proper use of hypoallergenic gloves to minimize exposure to irritants.

C) Monitor the patient's respiratory status and ensure adequate asthma control.

D) Instruct the patient to apply the topical corticosteroid more frequently to manage increased inflammation.

A patient with contact dermatitis complicated by a secondary Staphylococcus aureus infection is experiencing increased fatigue, mild dyspnea upon exertion, and slightly exacerbated asthma symptoms. As the nurse caring for this patient, which of the following interventions should be prioritized to address the patient's current condition?

B) Educate the patient on the importance of regular use of her albuterol inhaler to improve asthma control.

A) Encourage increased fluid intake to help manage the infection and support respiratory function.

B) Educate the patient on the importance of regular use of her albuterol inhaler to improve asthma control.

C) Advise the patient to avoid all physical exertion until respiratory symptoms subside completely.

D) Suggest the patient increase the frequency of topical corticosteroid application to reduce inflammation more quickly.

A patient with a history of asthma and dermatitis is undergoing treatment for a secondary skin infection and has shown partial improvement. During a follow-up visit, the nursing assessment reveals persistent fatigue and dyspnea. Which of the following nursing interventions is most appropriate to address the patient's current symptoms?

B) Reinforce the use of the newly prescribed inhaled corticosteroid.

A) Encourage increased physical activity to improve respiratory function.

B) Reinforce the use of the newly prescribed inhaled corticosteroid.

C) Suggest the use of over-the-counter antihistamines for fatigue.

D) Advise the patient to discontinue the use of skin barrier cream until dyspnea resolves.

A patient with a history of asthma and recent dermatitis treated with antibiotics presents with persistent dyspnea and vesicular lesions. Considering the current clinical presentation and the recent modifications to the patient's treatment plan, which nursing action is most critical in monitoring the patient's response to the adjusted asthma management plan?

A) Assess the patient's ability to perform activities of daily living without experiencing dyspnea

B) Monitor the patient's skin for any signs of new allergic reactions

C) Evaluate the patient's understanding of proper inhaler technique

D) Review the patient's dietary habits to identify potential allergens

A patient returns for a follow-up appointment with persistent fatigue, new pruritus, and erythematous patches on her forearms and neck. Her inhaled corticosteroid dosage was increased, and a systemic antihistamine was prescribed. Which nursing intervention is most appropriate to address the patient's current symptoms?

C) Instruct the patient to avoid scratching to prevent skin infection and worsening of dermatitis.

A) Educate the patient on proper inhaler technique to ensure optimal asthma management.

B) Advise the patient to increase fluid intake to help with fatigue and skin hydration.

C) Instruct the patient to avoid scratching to prevent skin infection and worsening of dermatitis.

D) Encourage the patient to take antihistamines at bedtime to reduce nighttime pruritus.

A patient with a history of asthma and recent skin lesions is experiencing persistent fatigue, pruritus, and dyspnea. Her eosinophil count is elevated, and new erythematous patches have developed on her forearms and neck. Which nursing intervention is most important to prioritize in her care plan at this time?

D) Monitor the patient's response to the newly prescribed systemic antihistamine to evaluate effectiveness.

A) Educate the patient on using a symptom diary to monitor skin changes and respiratory symptoms.

B) Initiate patient education on the proper use of inhaled corticosteroids to manage asthma symptoms.

C) Collaborate with the healthcare team to interpret the results of the allergen patch test once available.

D) Monitor the patient's response to the newly prescribed systemic antihistamine to evaluate effectiveness.

A patient with confirmed allergic contact dermatitis has been initiated on a short course of systemic corticosteroids due to extensive skin involvement and respiratory symptoms. As a nurse, what is the most important instruction to provide to the patient regarding the management of her condition?

B) Avoid exposure to identified allergens and continue documenting any new symptoms.

A) Increase the dosage of inhaled corticosteroids if respiratory symptoms worsen.

B) Avoid exposure to identified allergens and continue documenting any new symptoms.

C) Discontinue the use of all corticosteroids once the skin lesions resolve.

D) Reduce fluid intake to minimize the risk of fluid retention from corticosteroids.

A patient with allergic contact dermatitis secondary to nickel sulfate and fragrance mix presents with systemic spread of skin lesions and respiratory symptoms. Which nursing intervention is most appropriate to prioritize in this scenario to address both dermatological and respiratory manifestations?

D) Administer a short course of systemic corticosteroids as prescribed to address widespread inflammation.

A) Educate the patient on the application of topical corticosteroids directly on all skin lesions.

B) Monitor the patient’s peak expiratory flow rate to assess respiratory function regularly.

C) Instruct the patient to avoid allergens and maintain a symptom diary for ongoing symptom tracking.

D) Administer a short course of systemic corticosteroids as prescribed to address widespread inflammation.

A patient with a history of contact dermatitis and a new diagnosis of systemic lupus erythematosus (SLE) is being managed with systemic corticosteroids and hydroxychloroquine. The patient reports new symptoms of joint stiffness and mild swelling in her hands and knees. What is the most appropriate nursing intervention to address these symptoms in the context of her treatment plan?

B) Encourage range-of-motion exercises to maintain joint flexibility and reduce stiffness.

A) Educate the patient on the potential side effects of corticosteroids, such as weight gain and mood changes.

B) Encourage range-of-motion exercises to maintain joint flexibility and reduce stiffness.

C) Advise the patient to apply warm compresses to affected joints for immediate relief.

D) Monitor for signs of hydroxychloroquine toxicity, such as vision changes.

A patient with a recent diagnosis of systemic lupus erythematosus (SLE) and contact dermatitis is being treated with hydroxychloroquine and systemic corticosteroids. During a follow-up visit, the patient reports new joint stiffness and mild swelling. Which nursing intervention is most appropriate to address the patient's joint symptoms and promote comfort?

A) Advise the patient to apply warm compresses to affected joints to alleviate stiffness.

B) Suggest the patient perform high-impact exercises to improve joint mobility.

C) Recommend the use of over-the-counter NSAIDs for immediate relief of joint pain.

D) Encourage the patient to increase intake of calcium-rich foods to strengthen bones.

contact dermatitis - Nursing Case Study

Pathophysiology

• Primary mechanism: Contact dermatitis is primarily caused by the immune system's hypersensitivity reaction to an external substance, known as an allergen or irritant, that comes into contact with the skin. This triggers the release of inflammatory mediators like histamines, leading to skin inflammation and rash.

• Secondary mechanism: Langerhans cells in the epidermis play a crucial role by capturing the allergen and presenting it to T-cells, which become sensitized. Upon re-exposure to the same substance, these sensitized T-cells initiate a more rapid and robust immune response.

• Key complication: Repeated exposure to the allergen can lead to chronic dermatitis, characterized by skin thickening, scaling, and persistent itching, increasing the risk of secondary infections due to skin barrier disruption.

Patient Profile

Demographics:

32-year-old female, healthcare worker

History:

• Key past medical history: Asthma, seasonal allergies

• Current medications: Albuterol inhaler as needed, loratadine 10 mg daily

• Allergies: Penicillin

Current Presentation:

• Chief complaint: Itchy, red rash on both hands

• Key symptoms: Erythematous plaques with vesicles on the dorsal aspect of hands, pruritus, mild swelling, slight oozing

• Vital signs: Temperature 100.4°F, Heart rate 92 bpm, Blood pressure 128/84 mmHg, Respiratory rate 18 breaths per minute

Section 1

Following the initial assessment, the patient was advised to avoid known irritants and allergens, and a topical corticosteroid was prescribed to manage the inflammation and pruritus. However, within a week, the patient returned with worsening symptoms. Both hands now exhibited increased erythema and swelling, and new vesicles had formed, some of which were crusted over and had begun to ooze more significantly. The patient's temperature had risen to 101.2°F, and her heart rate had increased to 98 bpm, suggesting a possible secondary infection. Physical examination revealed lymphadenopathy in the axillary regions, and the patient reported feeling more fatigued than usual, experiencing mild dyspnea upon exertion.

Lab results indicated an elevated white blood cell count, with a neutrophil predominance, suggesting an inflammatory response likely complicated by bacterial infection. A wound culture was obtained from the oozing lesions, which later confirmed the presence of Staphylococcus aureus. The patient's asthma was also noted to be slightly exacerbated, possibly due to systemic inflammation or stress. Clinicians considered these findings in light of her occupation as a healthcare worker, which may have increased her exposure to potential allergens and pathogens.

In response to these complications, the treatment plan was adjusted. The patient was started on a course of oral antibiotics, and her topical corticosteroid was continued to manage the inflammation. Additionally, she was educated on more stringent protective measures, including wearing hypoallergenic gloves and maintaining meticulous hand hygiene to prevent further irritation and infection. The patient's asthma management was reviewed, and her albuterol inhaler use was monitored closely to ensure adequate respiratory support. This case now requires careful follow-up to assess the effectiveness of the new interventions and manage any further complications that might arise from the contact dermatitis or its treatment.

Section 2

Several days after the initiation of the oral antibiotic therapy, the patient returned for a follow-up appointment. She reported some improvement in the swelling and erythema of her hands, but the vesicular lesions were still present and oozing, albeit less significantly. Her temperature had decreased to 99.5°F, and her heart rate was now 88 bpm, suggesting a partial resolution of the secondary infection. However, the patient still experienced fatigue and noted that her dyspnea had not improved, particularly when performing routine tasks at work.

During this visit, additional laboratory tests were conducted. The latest complete blood count showed a modest decrease in the white blood cell count, though it remained slightly elevated, indicating that the infection was being managed but not yet fully resolved. Her eosinophil count was also slightly elevated, raising concerns about a possible allergic component contributing to her dermatitis. Lung function tests were performed to evaluate her asthma, revealing a slight decrease in peak expiratory flow rate, necessitating an adjustment in her asthma management plan.

Clinicians decided to modify the treatment strategy further. Given the incomplete resolution of the vesicular lesions and the persistent dyspnea, the antibiotic course was extended, and a skin barrier cream was introduced to protect the compromised skin from further damage. The patient's asthma medication regimen was adjusted to include a low-dose inhaled corticosteroid to address the underlying inflammation more effectively. The healthcare team emphasized the importance of continued protective measures, including avoiding potential allergens at work and at home. The patient was scheduled for another follow-up in one week to assess her response to these interventions and to monitor for any new complications that might arise.

Section 3

One week later, the patient returned for her scheduled follow-up appointment. Upon initial assessment, her vital signs revealed a stable temperature of 98.9°F and a heart rate of 84 bpm, indicative of further resolution of the systemic aspects of the infection. However, the patient reported persistent fatigue and a new development of pruritus that was particularly bothersome at night. On examination, the vesicular lesions on her hands showed signs of crusting and healing, but new erythematous patches were noted on her forearms and neck, suggesting potential spread or exacerbation of the dermatitis.

These findings prompted clinicians to consider a broader differential diagnosis. Given the elevated eosinophil count noted previously and the new distribution of skin lesions, there was heightened suspicion of an allergic contact dermatitis or a possible systemic allergic reaction. The healthcare team ordered a comprehensive allergen patch test to identify potential triggers and adjusted the treatment plan to include a systemic antihistamine to address the pruritus and any underlying allergic response. Additionally, further education on avoiding specific allergens and irritants was reinforced.

The patient's pulmonary function was reassessed, and while there was a slight improvement in her peak expiratory flow rate, the dyspnea persisted, particularly during exertion. This warranted an increase in the dosage of her inhaled corticosteroid to optimize asthma control. The ongoing symptoms and new skin findings underscored the complexity of her condition, requiring a multidisciplinary approach to address both the dermatologic and respiratory components effectively. The patient agreed to keep a symptom diary and was scheduled for another follow-up in two weeks to evaluate the impact of these interventions and to discuss the results of the allergen testing.

Section 4

Two weeks later, the patient returned for her follow-up appointment with a mixed response to the interventions. Her symptom diary indicated fluctuating levels of fatigue and intermittent pruritus, which she noted were somewhat alleviated by the antihistamine. Despite these efforts, her skin lesions had not fully resolved; instead, new erythematous and scaling patches had appeared on her lower legs and abdomen. On examination, the crusting lesions on her hands had healed, but the new distribution of rashes suggested a possible systemic involvement or an alternate diagnosis. Her vital signs remained stable, with a temperature of 98.6°F and a heart rate of 80 bpm, but her respiratory assessment revealed persistent mild wheezing and reduced breath sounds on auscultation, notably in the lower lung fields.

The results of the allergen patch test returned, revealing significant reactions to nickel sulfate and fragrance mix, which confirmed the suspicion of allergic contact dermatitis. However, the systemic spread of the lesions prompted further investigation into an underlying systemic allergic condition or a potential autoimmune component. A complete blood count was repeated, showing a persistent eosinophilia, and an antinuclear antibody (ANA) test was ordered to rule out systemic lupus erythematosus, considering the skin and respiratory manifestations.

The healthcare team recognized the need for a more comprehensive treatment strategy, incorporating both dermatological and immunological approaches. The patient's inhaled corticosteroid dosage was maintained, but a short course of systemic corticosteroids was initiated to manage the widespread dermatitis and associated inflammation. Furthermore, a referral to an allergist-immunologist was made to explore possible connections between her skin and respiratory symptoms, aiming to refine her management plan. The patient was educated on avoiding identified allergens and encouraged to continue documenting her symptoms, with a follow-up scheduled in another two weeks to reassess her progress and response to the new therapeutic regimen.

Section 5

Two weeks later, the patient returned for her scheduled follow-up, presenting with a mixed response to the updated treatment plan. Upon examination, her skin lesions had shown partial improvement; the erythematous and scaling patches on her lower legs and abdomen had diminished slightly in size and were less erythematous, suggesting some benefit from the systemic corticosteroids. However, the patient reported new symptoms of generalized joint stiffness and mild swelling, particularly in her hands and knees, which raised concerns about a potential systemic inflammatory process. Despite these developments, her respiratory symptoms remained stable, with no change in the mild wheezing or breath sounds, and her vital signs continued to be within normal limits, with a temperature of 98.7°F and a heart rate of 82 bpm.

New diagnostic results included the antinuclear antibody (ANA) test, which returned positive with a titer of 1:160 in a speckled pattern, indicating a possible autoimmune component to her condition. The eosinophilia persisted, with an eosinophil count slightly increased from the previous test, suggesting ongoing allergic or inflammatory processes. Given these findings, the healthcare team decided to adjust the treatment approach, considering the potential overlap of contact dermatitis with an autoimmune condition like systemic lupus erythematosus. The patient was initiated on hydroxychloroquine to address the joint symptoms and any underlying autoimmune activity, while continuing with the current corticosteroid regimen to manage the skin and respiratory manifestations.

The patient was educated on the new diagnosis and the importance of adherence to the revised treatment plan. She was advised to continue avoiding identified allergens and to monitor for any new symptoms or changes in her condition. A follow-up with the allergist-immunologist was scheduled to further explore the interplay between her allergic and autoimmune responses. The healthcare team emphasized the need for ongoing symptom documentation and scheduled another review in four weeks to evaluate her response to the new interventions and adjust her management plan as necessary.